This company listing is no longer active
GHSI Stock Overview
A clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Guardion Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.22 |
| 52 Week High | US$18.00 |
| 52 Week Low | US$3.04 |
| Beta | 0.71 |
| 1 Month Change | -0.92% |
| 3 Month Change | -66.53% |
| 1 Year Change | -47.56% |
| 3 Year Change | -95.16% |
| 5 Year Change | -95.93% |
| Change since IPO | -99.71% |
Recent News & Updates
Recent updates
Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper
Sep 22
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost
Jun 06Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Apr 10Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward
Feb 06Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues
Apr 17Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M
Aug 11Guardion Health closes Activ Nutritional acquisition
Jun 02Guardion Health initiates GlaucoCetin glaucoma trial
May 03The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More
Jan 15Guardion Health names industry veteran Bret Scholtes as new president and CEO
Dec 28Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?
Nov 24
Shareholder Returns
| GHSI | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -2.1% | -5.1% | -3.5% |
| 1Y | -47.6% | -24.9% | 22.1% |
Return vs Industry: GHSI underperformed the US Personal Products industry which returned 2.5% over the past year.
Return vs Market: GHSI underperformed the US Market which returned 36.8% over the past year.
Price Volatility
| GHSI volatility | |
|---|---|
| GHSI Average Weekly Movement | 27.2% |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GHSI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: GHSI's weekly volatility has increased from 18% to 27% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 9 | Mark Goldstone | www.guardionhealth.com |
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement.
Guardion Health Sciences, Inc. Fundamentals Summary
| GHSI fundamental statistics | |
|---|---|
| Market cap | US$4.35m |
| Earnings (TTM) | -US$5.28m |
| Revenue (TTM) | US$12.23m |
0.4x
P/S Ratio-0.8x
P/E RatioIs GHSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHSI income statement (TTM) | |
|---|---|
| Revenue | US$12.23m |
| Cost of Revenue | US$6.78m |
| Gross Profit | US$5.45m |
| Other Expenses | US$10.72m |
| Earnings | -US$5.28m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.91 |
| Gross Margin | 44.56% |
| Net Profit Margin | -43.14% |
| Debt/Equity Ratio | 0% |
How did GHSI perform over the long term?
See historical performance and comparisonDividends
155.3%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/01 08:55 |
| End of Day Share Price | 2024/10/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guardion Health Sciences, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Anthony Vendetti | Maxim Group |